Escalon Extends Product Portoflio with Third FDA Market Clearance Since
WAYNE, Pa., Jan. 29 /PRNewswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq: ESMC) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the VascuView(TM) Visual Ultrasound System for use with assisted vascular access. Its subsidiary, Escalon Vascular Access, Inc., plans to commence shipments of the product in the United States immediately.
"We are excited to announce the FDA clearance and introduction of the new VascuView(TM) Visual Ultrasound System," said Michael O'Donnell, President of Escalon Vascular Access. "Developed with doctors and clinicians ultrasound needs in mind, the VascuView(TM) system couples unparalleled portability with a large image display and intuitive touchscreen operation which allow users to focus on the task at hand. Whether mounted on a stand, used table top bedside, or fit into a carrying case for field use, the VascuView(TM) is highly adaptable to the challenges of varying departmental environments within a hospital."
Richard J. DePiano Jr., President of Escalon Medical Corp. commented, "The clearance of the VascuView(TM) system is a very promising milestone as it not only reflects the successful culmination of our research and development efforts but represents our third FDA market clearance in the last six weeks. We remain committed to meeting the needs of the clinical community by delivering innovative and cost-effective technologies."
The VascuView(TM) Visual Ultrasound System utilizes a tablet pc with
software built on the Microsoft Windows XP platform. The probe itself
|SOURCE Escalon Medical Corp.|
Copyright©2008 PR Newswire.
All rights reserved